EOS imaging: Implementation of Programmed Trading Mandates

Regulatory News:

EOS Imaging (Paris:EOSI) (NYSE Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announces that Edmond de Rothschild Investment Partners, and NBGI Private Equity Limited have informed the Company that they have each entrusted a programmed trading mandate to brokerage firm Kepler Cheuvreux.

These programmed trading mandates relate to the divestment of a maximum of 1,278,968 shares, representing approximately 6.96% of EOS imaging’s capital at August 1, 2014, over a maximum period of 12 months from July 24, 2014. This reflects the intention of these shareholders, who are represented on the EOS imaging Board, of organizing stock divestments in a centralized and structured way, which has been made necessary by the maturing of some funds over the period. These mandates comply with the "Autorité des Marchés Financiers” Recommendation n°2010-07 of November 3, 2010.

About EOS imaging:

EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 31 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of 90 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2013 the Group posted 2013 consolidated revenue of €15.2 million and employed 101 people including an R&D team of 38 engineers. The Group is based in Paris and holds four subsidiaries in Besançon (France), Cambridge (Massachusetts), in Montreal (Canada) and Frankfurt (Germany), and offices in Singapore. For further information, please visit www.eos-imaging.com

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

Next press release: results for the 1^st half of 2014, on September 1, 2014 (after market).